Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Aurobindo Pharma Ltd. Unit-XII.
Aurobindo Pharma Ltd. Unit-XII: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Side by side
Aurobindo Pharma Ltd. Unit-XII — Warning letters0
Philips North America — Warning letters0
Aurobindo Pharma Ltd. Unit-XII — Recalls0
Philips North America — Recalls355
Aurobindo Pharma Ltd. Unit-XII — Approval records0
Philips North America — Approval records0
Aurobindo Pharma Ltd. Unit-XII — Form 483s1
Philips North America — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Aurobindo Pharma Ltd. Unit-XII vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/aurobindo-pharma-ltd-unit-xii-vs-philips-north-america
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗